Exchange: NYSEMkt·Updated 07:30 PM EST

About MAIA

About

MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.

Official Representatives

Sector:
Health Technology
Industry:
Biotechnology
Employees:
13

Frequently Asked Questions

Advertisement|Remove ads.